SCHEMBL4232199

SCHEMBL4232199

[CH2]C=CC=CCCCCCCC

nearest known ligand 0.56

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.56
ALDH1A1 P00352 1/20 0.56
FASN P49327 1/20 0.53
FAAH O00519 4/20 0.48
TRPV1 Q8NER1 1/20 0.48
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.42
CYP3A4 P08684 1/20 0.42
KMT2A Q03164 1/20 0.42
CNR1 P21554 1/20 0.42
CNR2 P34972 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19973770 1.00 TSHR (0.56) TSHRALDH1A1FASNFAAHTRPV1
SCHEMBL3718542 1.00 TSHR (0.56) TSHRALDH1A1FASNFAAHTRPV1
SCHEMBL19973653 1.00 TSHR (0.56) TSHRALDH1A1FASNFAAHTRPV1
SCHEMBL25181839 1.00 TSHR (0.56) TSHRALDH1A1FASNFAAHTRPV1
SCHEMBL19973816 1.00 TSHR (0.56) TSHRALDH1A1FASNFAAHTRPV1
SCHEMBL25186124 1.00 TSHR (0.56) TSHRALDH1A1FASNFAAHTRPV1
SCHEMBL23493108 1.00 TSHR (0.56) TSHRALDH1A1FASNFAAHTRPV1
SCHEMBL23493109 1.00 TSHR (0.56) TSHRALDH1A1FASNFAAHTRPV1
SCHEMBL19973745 1.00 TSHR (0.56) TSHRALDH1A1FASNFAAHTRPV1
SCHEMBL19973747 1.00 TSHR (0.56) TSHRALDH1A1FASNFAAHTRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009131692-A1 SUBSTRATES FOR DELIVERY OF PHYSIOLOGICALLY ACTIVE AGENTS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) 2009-10-29 WO claimed
EP-0980203-B1 ANTIMICROBIAL PREVENTION AND TREATMENT OF HUMAN IMMUNEDEFICIENCY VIRUS AND OTHER INFECTIOUS DISEASES SQUIRES MERYL (US) 2007-04-04 EP claimed
EP-0832898-A2 Substituted amino acid derivatives BAYER AG (DE) 1998-04-01 EP claimed
CN-109715605-B Process for preparing carotenoid monoesters 巴斯夫欧洲公司 2022-04-12 CN disclosed
US-20220017556-A1 METHODS FOR PRODUCING STEREOISOMERICALLY ENRICHED CARBOHYDRATE-BASED SURFACTANTS ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2022-01-20 US disclosed
US-20210403499-A1 CARBOHYDRATE-BASED SURFACTANTS ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2021-12-30 US disclosed
US-11117914-B2 Carbohydrate-based surfactants ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2021-09-14 US disclosed
WO-2018050792-A1 PROCESS FOR PREPARING ESTERS OF 12'-APOCAROTENALS AS BUILDING BLOCKS FOR CAROTENOIDS BASF SE (DE) 2018-03-22 WO disclosed
WO-2018050795-A1 PROCESS FOR PREPARING OF CAROTENOID MONO-ESTERS BASF SE (DE) 2018-03-22 WO disclosed
WO-2018050793-A1 PROCESS FOR PREPARING PHOSPHONIUM SALT ESTERS AS BUILDING BLOCKS FOR CAROTENOIDES BASF SE (DE) 2018-03-22 WO disclosed
WO-2018050794-A1 PROCESS FOR PREPARING OF CAROTENOID MONO-ESTERS BASF SE (DE) 2018-03-22 WO disclosed
WO-1999000377-A1 PRO-FRAGRANCE CYCLIC ACETALS THE PROCTER & GAMBLE COMPANY (US) 1999-01-07 WO disclosed
WO-1999000347-A1 PRO-FRAGRANCE LINEAR ACETALS AND KETALS THE PROCTER & GAMBLE COMPANY (US) 1999-01-07 WO disclosed
WO-1998047996-A1 LAUNDRY DETERGENT COMPOSITIONS COMPRISING FRAGRANCE PRO-ACCORDS THE PROCTER & GAMBLE COMPANY (US) 1998-10-29 WO disclosed
WO-1998047995-A1 ORTHOCARBONATE PRO-FRAGRANCES THE PROCTER & GAMBLE COMPANY (US) 1998-10-29 WO disclosed
WO-1998047477-A1 FRAGRANCE PRO-ACCORDS THE PROCTER & GAMBLE COMPANY (US) 1998-10-29 WO disclosed
WO-1998047478-A1 PERFUMES HAVING ODOR LONGEVITY BENEFITS THE PROCTER & GAMBLE COMPANY (US) 1998-10-29 WO disclosed
EP-0832898-A2 Substituted amino acid derivatives BAYER AG (DE) 1998-04-01 EP disclosed
WO-1998006803-A1 RINSE ADDED FABRIC SOFTENING COMPOSITIONS AND METHOD OF USE FOR THE DELIVERY OF FRAGRANCE PRECURSORS THE PROCTER & GAMBLE COMPANY (US) 1998-02-19 WO disclosed
EP-0780382-A1 S-Triazine derivatives as sunscreen agents for cosmetics GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) 1997-06-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11117914-B2 Carbohydrate-based surfactants DDOST, CSGALNACT1, MUC1 TSHR 2658/4885ALDH1A1 4431/4885FASN 167/4885
US-20210403499-A1 CARBOHYDRATE-BASED SURFACTANTS DDOST, CSGALNACT1, MUC1 TSHR 2658/4885ALDH1A1 4431/4885FASN 167/4885
US-20220017556-A1 METHODS FOR PRODUCING STEREOISOMERICALLY ENRICHED CARBOHYDRATE-BASED SURFACTANTS DDOST, CEL, SI TSHR 4370/4885ALDH1A1 3813/4885FASN 174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.